Literature DB >> 7050041

An explanation for the ability of cytotoxic drug pretreatment to reduce bone marrow related lethality of total body irradiation (TBI).

J L Millar, T C Stephens, E A Wist.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 7050041     DOI： 10.1016/0360-3016(82)90688-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  3 in total

1.  Priming with low doses of methyl-CCNU reduce the toxicity of high doses of methyl-CCNU and melphalan, and increase the lifespan of mice implanted with Lewis lung carcinoma.

Authors:  A Zimber; K Perk; I Livnat
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

2.  Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Expanded In Vitro for Treatment of Aplastic Anemia: A Multicenter Phase II Trial.

Authors:  Yan Pang; Hao-Wen Xiao; Hang Zhang; Zeng-Hui Liu; Li Li; Yang Gao; Hong-Bo Li; Zu-Jun Jiang; Huo Tan; Jing-Ren Lin; Xin Du; Jian-Yu Weng; Da-Nian Nie; Dong-Jun Lin; Xiang-Zhong Zhang; Qi-Fa Liu; Duo-Rong Xu; Hai-Jia Chen; Xiao-Hu Ge; Xiao-Yan Wang; Yang Xiao
Journal:  Stem Cells Transl Med       Date:  2017-05-15       Impact factor: 6.940

3.  High dose cyclophosphamide treatment of human oat cell xenografts in immune deprived mice.

Authors:  B D Evans; I E Smith; J L Millar
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.